Skip to content
DataLookout
Menu

NCT04325529

Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 10 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 14 versions: 13 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jun 30, 2026 to Apr 30, 2027
    • Eligibility criteria expanded, about 23 words
  2. Notable Primary and study completion dates pushed to Jun 30, 2026v13
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 96 to confirmed 148
    • Site details revised
    v12
  4. Notable Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v11
  5. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
Show 7 earlier versionsHide 7 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2022 to Jan 19, 2021
    • Site details revised
    v9
  2. Notable Start date: Dec 1, 2020 to Oct 1, 2022
    • Trial status: Recruiting to Not Yet Recruiting
    • Site details revised
    v8
  3. Minor Study title shortened, about 1 wordv6
  4. Minor Primary completion date: Dec 1, 2025 to Mar 31, 2025
    • Start date: Jan 15, 2021 to Dec 1, 2020
    v5
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  6. Notable Start date: Dec 1, 2020 to Jan 15, 2021v3
  7. Notable Enrollment target: 208 to 96v2 Show 6 more changesShow less
    • Start date: Sep 1, 2020 to Dec 1, 2020
    • Eligibility criteria shortened, about 42 words
    • Primary endpoints: 6 to 5
    • Interventions: BTRX-246040 (Drug) to Aversive stimuli (Device)
    • Study description shortened, about 61 words
    • Study arms: 3 to 2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Clinical Interview
Timeframe: Baseline
Behavioral Performance on the Probabilistic Reward Task (PRT)
Timeframe: Baseline
MRI Data
Timeframe: MRI scans take place within 30 days of Screening Visit
Salivary Cortisol
Timeframe: Baseline
Follow-up Clinical interviews
Timeframe: Change from Baseline at 6 months and 12 months after the MRI scanning visit

Arms and interventions

remitted MDD

Unmedicated Remitted Participants with Past History of MDD

Control subjects

healthy control subjects

Devices: Aversive stimuli

Sites

1 site in 1 country

  • McLean HospitalBelmont, Massachusetts, United States